Role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia

Journal of Inherited Metabolic Disease

Volumn 20, Issue 2, 1997, Pages 316-325

  Ubbink, J B ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; VITAMIN;

BLOOD LEVEL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MEGADOSE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; NUTRITIONAL STATUS; PATHOGENESIS;

HOMOCYSTEINE; HUMANS; NUTRITIONAL STATUS; VITAMINS;

EID: 0030968144     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005329427711     Document Type: Conference Paper

References (48)

1. Allen RH, Stabler SP, Savage DG, Lindenbaum J (1990) Diagnosis of cobalamin deficiency 1: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 34: 90-98.
2. Arnadottir M, Brattström L, Simonsen O, et al (1993) The effect of high dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 40: 236-240.
3. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE (1995) Serum total homocysteine and coronary heart disease. Int J Epidemiol 24: 704-709.
4. Brattström LE, Israelsson B, Jeppson JO, Hultberg BL (1988) Folic acid - an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 48: 215-221.
5. Bostom AG, Jacques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J (1995) Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis 116: 147-151.
6. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. J Am Med Assoc 274: 1049-1057.
7. Brody T (1991) Folic acid. In Machlin LJ, ed. Handbook of Vitamins. New York: Marcel Dekker, 453-489.
8. Carey MC, Fennelly JJ, Fitzgerald O (1968) Homocystinuria: subnormal serum folate levels, increased folate clearance and effects of folic acid therapy. Am J Med 45: 26-30.
9. Carson NAJ, Carre D (1969) Treatment of homocystinuria with pyridoxine. A preliminary study. Arch Dis Child 44: 387-392.
10. Chauveau P, Chadefaux B, Coude M, Aupetit J, Kamoun P, Jungers P (1996) Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab 22: 106-109.
11. Chern CJ, Beutler E (1975) Pyridoxal kinase: decreased activity in red blood cells of AfroAmericans. Science 187: 1084-1086.
12. Clarke R, Daly L, Robinson K, et al (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324: 1149-1155.
13. 6, pyridoxal phosphate and folate. Am J Cardiol 75: 1107-1111.
14. 12, plasma absorption. J Clin Invest 36: 1551-1557.
15. Dudman NPB, Wilcken DEL, Wang N, Lynch JF, Macey D, Lundberg P (1993) Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 13: 1253-1260.
16. 12, In Machlin LJ, ed. Handbook of Vitamins. New York: Marcel Dekker, 491-536.
17. 6 and folic acid on mild hyperhomocysteinaemia in vascular patients. J Inher Metab Dis 17: 159-162.
18. Franken DG, Boers GHJ, Blom HJ, Trijbels FJM, Kloppenborg PWC (1994b) Treatment of mild hyperhomocysteinemia in vascular disease patients. Arterioscler Thromb 14: 465-470.
19. 12 therapy. J Pediatr 98: 275-278.
20. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR (1995) Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol 15: 1314-1320.
21. Israelsson B, Brattström LE, Hultberg BL (1988) Homocysteine and myocardial infarction. Atherosclerosis 71: 227-233.
22. 6 occur commonly in elderly people. Am J Clin Nutr 58: 468-476.
23. Kang S, Wong, PWK, Norusis M (1987) Homocysteinemia due to folate deficiency. Metabolism 36: 458-462.
24. Landgren F, Israelsson B, Hultberg B, Anderson A, Brattström L (1995) Plasma homocysteine in acute myocardial infarction: homocysteine lowering effect of folic acid. J Intern Med 237: 381-388.
25. Lindenbaum J, Healton EB, Savage DG, et al (1988) Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318: 1720-1728.
26. McCormick DB, Gregory ME, Snell EE (1961) Pyridoxal phosphokinases. Assay, distribution, purification, and properties. J Biol Chem 236: 2076-2084.
27. Mudd SH, Skovby F, Levy HL, et al (1985) The natural history of homocystinuria due to cystathionine-synthase deficiency. Am J Hum Genet 37: 1-31.
28. Mudd SH, Levy HL, Skovby F (1989) Disorders of transsulfuration. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease, 6th edn, vol. 1. New York: McGraw-Hill, 693-734.
29. 6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346: 85-89.
30. 12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59: 940-948.
31. 6 depletion in adult man on the excretion of cystathionine and other methionine metabolites. J Nutr 100: 110-116.
32. Rasmussen K, Møller J, Lyngbak AM, Holm-Pedersen M, Dybkjaer L (1996) Age- and gender-specific intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 42: 630-636.
33. Schaumburg H, Kaplan J, Windebank A, et al (1983) Sensory neuropathy from pyridoxine abuse. N Engl J Med 309: 445-448.
34. Selhub J, Miller JW (1992) The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55: 131-138.
35. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. J Am Med Assoc 270: 2693-2698.
36. Selhub J, Jacques PF, Bostom AG, et al (1995) Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332: 286-29.
37. Stabler SP, Marcell PD, Podell ER, Allen RH, Savage G, Lindenbaum J (1988) Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 81: 466-474.
38. Stampfer MJ, Malinow R, Willet WC, et al (1992) A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 268: 877-881.
39. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al (1994) Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43: 1475-1480.
40. Stipanuk H (1986) Metabolism of sulfur-containing amino acids. Annu Rev Nutr 6: 179-209.
41. 6 and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 57: 47-53.
42. Ubbink JB, van der Merwe A, Vermaak WJH, Delport R (1993b) Hyperhomocysteinemia and the response to vitamin supplementation. Clin Invest 71: 993-998.
43. Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ, Delport R, Potgieter HC (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 124: 1927-1933.
44. Ubbink JB, Vermaak HJH, van der Merwe A, Becker PJ, Potgieter H (1995) Effective homocysteine metabolism may protect South African Blacks against coronary heart disease. Am J Clin Nutr 62: 802-808.
45. 6 status on homocysteine metabolism. J Clin Invest 98: 177-184.
46. Ubbink JB, Becker PJ, Vermaak WJH (1996b) Will an increased dietary folate intake reduce the incidence of cardiovascular disease? Nutr Rev, 54: 213-216.
47. 6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vasc Surg 20: 933-940.
48. 6 and coronary artery disease. Epidemiological observations and case studies. Atherosclerosis 63: 235-238.